News | First implants of TX2 thoracic endograft completed | Which Medical Device

The completion of the first implants of the Zenith TX2 Low Profile TAA Endovascular Graft (Cook Medical) took place in May 2010, as part of a clinical investigation, by assistant Professor Piotr Kasprzak, head of vascular surgery at the University Hospital Regensburg, Germany.

At 16F or 18F, the TX2 Low Profile delivery system is smaller than a standard TX2 device and is engineered to allow patients with challenging anatomies to be treated percutaneously. As a result, patients who previously may not have been suited to thoracic endovascular repair, for example those with narrowed, small or tortuous arteries, may now benefit from minimally invasive treatment.

Up to ten medical centres across Europe may take part in the TX2 Low Profile TAA study. Kasprzak said: “Treating an aneurysm with the TX2 Low Profile TAA from Cook Medical shows great promise. With this stent we’re able to treat patients with TEVAR. The TX2 Low Profile may provide a viable alternative to open surgery that may result in lower risks of complications to a larger patient population.”